|
Quotes & Info
|
| PRXI > SEC Filings for PRXI > Form 10-Q on 10-Jul-2009 | All Recent SEC Filings |
10-Jul-2009
Quarterly Report
Dialog in the Dark
On February 25, 2008, we expanded our exhibition portfolio beyond those
related to the Titanic and human anatomy when we entered into a long-term
license agreement to present an exhibition series entitled "Dialog in the Dark."
Our "Dialog in the Dark" exhibitions are intended to provide visitors with an
opportunity to experience the paradox of learning to "see" without the use of
sight. Visitors are escorted through a series of galleries immersed in total
darkness and challenged to perform tasks without the use of vision. Our first
"Dialog in the Dark" exhibition opened in August 2008.
Star Trek
On June 4, 2008, we entered into a long-term license agreement to present,
promote and conduct "Star Trek, The Exhibition" exhibitions. This multi-city,
touring exhibition contains the world's most comprehensive collection of
authentic Star Trek ships, sets, costumes and props from five television series
and ten films over the last 40 years. "Star Trek, the Exhibition" fully immerses
the visitor in the legendary journey that has become synonymous with scientific
innovation and ingenuity. Highlights of the experience include: the opportunity
to ride through a Star Trek adventure in full-motion, Star Trek-based flight
simulators; the ability for visitors to sit on a full-size U.S.S. Enterprise
bridge from the original television series; and detailed re-creations of
original sets.
Merchandise
We also earn revenue from the sale of merchandise, such as apparel, catalogs,
posters and Titanic-related jewelry (which utilizes coal we have recovered from
the shipwreck). In addition, we also publish exhibition catalogs, which are sold
at our exhibition gift shops.
Information Regarding Exhibitions Outside the United States
Our exhibitions regularly tour outside the United States. Approximately 16%
and 13% of our revenues in the quarter ended May 31, 2009 and 2008,
respectively, resulted from exhibition activities outside the United States.
Because our financial arrangements with our foreign vendors have historically
been based upon foreign currencies, we are exposed to the risk of currency
fluctuations between the U.S. dollar and the currencies of the countries in
which our exhibitions are touring. See "Quantitative and Qualitative Disclosures
About Market Risk" in this report for more information.
The Quarter Ended May 31, 2009 Compared to the Quarter Ended May 31, 2008
Revenue. During the quarter ended May 31, 2009, our revenue decreased by
$4.3 million or 28.2% to $10.9 million. Our exhibition revenue decrease of
$3.4 million or 25.7% to $9.8 million is primarily attributable to the general
decline in economic conditions, which resulted in a decrease in total attendance
at our exhibition venues. Attendance decreased to 1,188,219 for the three months
ended May 31, 2009 compared to 1,520,046 for the same three month period ended
May 31, 2008. Total days of operation, a non-financial measurement, which is the
total number of days in which our venues were in operations, increased to 1,624
for the three months ended May 31, 2009 compared to 1,598 for the same three
months ended May 31, 2008.
Merchandise and other revenue decreased approximately $0.9 million or 44.9%
to $1.1 million during the quarter ended May 31, 2009 as compared to the quarter
ended May 31, 2008, is primarily the result of the disposition of the live music
aspect of our merchandising business, in which we recognized an additional
$1.3 million of merchandise revenue during the quarter last year.
Cost of revenue. Our total cost of revenue of $5.1 million, which consists of
exhibition costs, including marketing expenses, and cost of merchandise sold,
decreased by $2.2 million or 29.9% for our first quarter ended May 31, 2009 as
compared to our first quarter ended May 31, 2008.
Our exhibition costs decreased by $1.4 million or 23.1% to $4.9 million for
our first quarter this year as compared to the same quarter in fiscal year 2009.
Our exhibition costs as a percentage of revenue was 47% for the three months
ending May 31, 2009 compared to 48.1% for the same period last year.
Marketing expense decreased by $1.3 million or 82.9% to $0.3 million during our
first quarter ended May 31, 2009 as compared to our first quarter ended May 31,
2008.
Cost of merchandise sold decreased by $0.7 million or 74.1% to $0.3 million
for the quarter ended May 31, 2009 as compared to the quarter ended May 31,
2008, is primarily a result of the disposition of the live music aspect of our
merchandising business.
Gross profit. During the quarter ended May 31, 2009, our gross profit
decreased $2.1 million or 26.6% to $5.8 million as compared to the quarter ended
May 31, 2008. The decrease in our gross profit is primarily attributable to the
general decline in market conditions resulting in decreased revenue, which
prompted the storage of several human anatomy sets. Gross profit margin was
53.0% and 51.9% for the quarters ended May 31, 2009 and 2008, respectively.
Operating expenses. Our general and administrative expenses of $7.3 million
decreased $0.7 million or approximately 8.7% during the quarter ended May 31,
2009 as compared to the quarter ended May 31, 2008. The decrease in general and
administrative expenses is primarily attributable to reduced compensation
expense of 35.6%, reduced travel and office expense of 89.9% and reduced stock
compensation expense of 83.8%. These reductions were partially offset by
licensing fees for non-operating human anatomy sets and the marketing function
provided by an outside vendor totaling $1.1 million.
Our depreciation and amortization expenses increased $0.3 million or 25.6% to
$1.6 million during the quarter ended May 31, 2009 as compared to the quarter
ended May 31, 2008, which is primarily attributable to an increase in property
and equipment located at the Luxor in Las Vegas.
In the first quarter, management assessed the amount of human anatomical
displays it has to exhibit and compared that amount to the estimated addressable
market for such exhibitions. In management's judgment, the company currently
maintains an excess capacity of human anatomical displays, and we intend to
reduce the amount of capacity by negotiating a return of certain specimens.
Consequently, those specimens have no future estimated cash flows associated
with them and the previously capitalized and yet unamortized costs of such
specimens are no longer considered recoverable; therefore, we recorded an
impairment charge of $1.9 million to reduce the carrying value of the finite
lived intangibles related to those specimens to zero. Because there was goodwill
associated with the original acquisition of those specimen sets, we recorded an
impairment charge of $2.6 million to reduce the carrying value of goodwill to
zero.
Loss from operations. We realized a loss from operations of $7.7 million
during the quarter ended May 31, 2009 as compared to a loss from operations of
$1.4 million in the same prior year period.
Loss before benefit from income taxes. We realized a net loss before
provision for income taxes of $7.7 million and $1.3 million for the quarters
ended May 31, 2009 and 2008, respectively.
Benefit from income taxes. We recorded an income tax benefit of $1.9 million
for the three months ended May 31, 2009 at an effective rate of 25% versus a tax
benefit of $0.4 million at an effective rate of 32% for the same period in the
prior year. The decrease in the effective rate is primarily due to the
impairment charge of $4.5 million that is not a tax deductible item;
accordingly, it is not considered in the tax benefit calculation. Not
considering the non-deductibility of the impairment charge, our effective tax
rate would have been 37%.
Net loss. We realized a net loss of $5.8 million during the quarter ended
May 31, 2009 as compared to a net loss of $0.9 million in the prior year period.
Loss per share. Basic and diluted loss per common share for the quarters
ended May 31, 2009 and 2008 was $(0.20) and $(0.03), respectively. The basic and
diluted weighted average shares outstanding for each of the quarters ended
May 31, 2009 and 2008 were 29,696,954 and 30,041,614, respectively.
|
|